跳至主要内容
临床试验/IRCT20240327061376N1
IRCT20240327061376N1已完成Unknown

Efficacy of Oral Tacrolimus Combined With Rectal Indomethacin Compared to Rectal Indomethacin Alone in Reducing Pancreatitis After ERCP

Mashhad University of Medical Sciences0 个研究点目标入组 78 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
已完成
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Normal amylase and lipase levels before ARCP
  • All patients who meet the criteria for performing RCPI
  • Having informed consent
  • Full consciousness
  • No contraindications for tacrolimus

排除标准

  • Pregnancy or breastfeeding
  • History of previous angina, myocardial infarction, cerebral ischemia during the previous three months
  • Chronic heart, liver and kidney failure
  • Referral with manifestations of acute pancreatitis or chronic pancreatitis
  • Tacrolimus contraindications include: uncontrolled blood pressure, uncontrolled infections, hypomagnesemia, hypocalcemia, hyperkalemia, and any type of malignancy.
  • Heart rhythm disorders
  • Thrombosis and DVT

研究者

相似试验